Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day

DuPont is now marketing Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day.

Sustiva is a non-nucleoside reverse transcriptase inhibitor (NNRTI)...in the same class as Rescriptor and Viramune.

It seems to be as potent as a protease inhibitor...when combined with Retrovir (zidovudine) and Epivir (lamivudine).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote